The global Enzyme-Linked Immunosorbent Assay (ELISA) market was valued at USD 2.29 billion in 2025, projected to reach USD 3.63 billion by 2033, with a CAGR of 5.98%. More than 50 million ELISA tests are performed annually worldwide, primarily in clinical diagnostics, pharmaceuticals, and food safety.
ELISA is a well-established immunoassay technique used for detecting and quantifying proteins, antibodies, hormones, and pathogens. In 2025, ELISA-based diagnostic kits formed the backbone of testing in both developed and emerging markets due to their precision and versatility.
Sandwich ELISA held the largest market share of 36.15% in 2025, with competitive ELISA expected to grow at the highest CAGR of 7.39%. Clinical Diagnostics contributed the highest share of 56.80%, with Pharmaceutical & Biotech Testing projected to grow at the fastest CAGR of 7.68%.
North America leads the global ELISA market with a 42.23% share in 2025, while the Asia Pacific market is projected to grow at a CAGR of 7.06% during 2026–2033, making it the fastest-growing region globally. Major players in the market include Thermo Fisher Scientific, Bio-Rad Laboratories, and Merck KGaA.
In July 2025, Thermo Fisher Scientific announced the acquisition of Solventum’s purification and filtration business for approximately USD 4.1 billion. In May 2025, Bio-Rad Laboratories expanded its portfolio by introducing new anti-idiotypic antibodies and SpyCatcher reagents. The Global Test Volume & Utilization Intelligence in the Enzyme-Linked Immunosorbent Assay (ELISA) market helps identify high-consumption markets and expansion opportunities. Product Mix Penetration Analytics uncovers assay classes dominating testing consumption. End-User Deployment Intensity Index maps ELISA infrastructure readiness. Application-Level Demand Drivers reveal shifting demand trends. Regional Market Penetration Benchmarks compare adoption across regions.
The ELISA market is projected to reach USD 3.63 billion by 2033, with a CAGR of 5.98% from 2026 to 2033. Key segments include product types (Direct, Indirect, Sandwich, Competitive ELISA) and applications (Clinical Diagnostics, Research, Food & Beverage Testing). Regional analysis covers North America, Europe, Asia-Pacific, LATAM, and MEA.
SNS Insider offers detailed market research and consulting services globally. By providing clients with current and accurate market data, consumer insights, and opinions, the company aims to help businesses make informed decisions in changing circumstances. Techniques used include surveys, video talks, and focus groups worldwide. For more information, visit the link provided.
Read more at GlobeNewswire: Enzyme-Linked Immunosorbent Assay (ELISA) Market to Reach